Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL   US05334D1072

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

05/24/2012 | 07:58am US/Eastern
Recommend:
0

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

Recommend :
0
React to this article
Latest news on AUXILIUM PHARMACEUTICALS,
07/10 AUXILIUM PHARMACEUTICALS : Willie Briscoe and Powers Taylor Probe Auxilium Pharm..
07/09 AUXILIUM PHARMACEUTICALS : Newman Ferrara LLP Announces Investigation of Auxiliu..
07/07 AUXILIUM PHARMACEUTICALS : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the In..
07/07 AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Inv..
07/02 AUXILIUM PHARMACEUTICALS : to combine with eye drug maker QLT
07/02 AUXILIUM PHARMACEUTICALS : to Merge with Canadian Biotechnology Company QLT
07/02 AUXILIUM PHARMACEUTICALS : The Wohl & Fruchter LLP Law Firm is Investigating the..
07/02 AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Brower Piven Announces The Investi..
06/30 AUXILIUM PHARMACEUTICALS : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces I..
06/30 AUXILIUM PHARMACEUTICALS : Newman Ferrara LLP : Announces Investigation of Auxil..
Advertisement
Chart
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | AUXL | US05334D1072 | 4-Traders
Income Statement Evolution
Auxilium Pharmaceuticals,  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF